<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="134514">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01949779</url>
  </required_header>
  <id_info>
    <org_study_id>T4023</org_study_id>
    <nct_id>NCT01949779</nct_id>
  </id_info>
  <brief_title>TransForm™ Occlusion Balloon Catheter Registry</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stryker Neurovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stryker Neurovascular</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this registry is to collect real world data on the safety and
      performance of the TransForm™ Occlusion Balloon Catheter when used in current
      neurointerventional procedures
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  This is a prospective, single-arm, non-randomized, multi-center, observational
           registry.

        -  The expected duration for study enrollment is approximately 6 months-1 year.

        -  Study participation for each subject will be completed upon removal of the guide
           catheter post-procedure.

        -  Approximately 70 subjects will be enrolled at up to 7 study sites (approximately 5
           sites in the United States and 2 sites internationally).  Each site will be allowed to
           enroll up to a maximum subject of 15 subjects per site.

        -  Enrollment in the registry occurs after a signed Informed Consent Form has been
           obtained, and the index procedure starts.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>The ability of the TransForm™ Occlusion Balloon Catheter to reach the target site.</measure>
    <time_frame>Day 1 of the index procedure</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Neurointerventional Procedure</condition>
  <arm_group>
    <arm_group_label>TransForm OBC</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TransForm Occlusion Balloon Catheter</intervention_name>
    <arm_group_label>TransForm OBC</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        primary care/hospitals
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject or legal representative is willing and has provided informed consent.

          2. Subject is scheduled to undergo a neurointerventional procedure that may include the
             use of the occlusion balloon catheter.

          3. Subject is over 18 years of age.

        Exclusion Criteria:

          1. Subject's anatomy precludes safe delivery of the TransForm Occlusion Balloon
             Catheter.

          2. Subject's pregnant
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Central Baptist</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Birk</last_name>
      <phone>859-260-6950</phone>
      <email>sara.birk1@bhsi.com</email>
    </contact>
    <investigator>
      <last_name>Curtis Given</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>kathy Jelinek</last_name>
      <phone>614-688-6853</phone>
      <email>Kathryn.Jelinek@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Eric Sauvageau</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West Virginia University</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Domico</last_name>
      <phone>304-598-6930</phone>
      <email>domicoj@wvuhealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Ansaar Rai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>January 6, 2014</lastchanged_date>
  <firstreceived_date>September 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
